Autopsy report · NCT00927602
Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency
Cause of deathSlow enrollment
“study was stopped after enrolment of about 200 patients for slow recruitment”
Life of this trial
- Registered 2 months after it had already started.
- Ran for about 2 years 11 months before it stopped.
- 206 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Università degli Studi dell'Insubria
- Sponsor type
- University, hospital or other
- Conditions
- Medical Patients; Renal Insufficiency
- Interventions
- fondaparinux
- Participants
- 206
- Sites
- 1
- Countries
- Italy
Trials that died the same way
- Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
“Study stopped due to difficulties in patient recruitment” - All-On-4® Treatment Concept
“The study stopped as the performance of the study showed insufficient patient recruitment.” - Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease
“Recruitment was stopped early due to slow enrolment of this population. With no safety concerns, the study continued normally for subjects already recruited” - A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression
“Study terminated due to slow patient recruitment.” - Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor
“Study halted due to slow recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.